The MECC philosophy is more than just shorter tubing
With isolated cardiotomy suction, the external venous reservoir eliminated and priming volume significantly reduced, MECC is a more atraumatic solution for the patient.
MECC’s compact and less invasive approach has opened the door for a closer cooperation between surgeon, perfusionist and anaesthesiologist resulting in optimized patient management.
This minimized perfusion approach has opened the door to new patient management.
The MECC System includes
- The MECC Set, consisting of the Quadrox-i Oxygenator with or without integrated arterial filter, the VBT 160 Venous Bubble Trap, the Rotaflow RF-32 Centrifugal Pump as well as various consumables, all provided with Bioline Coating,
- Cannulae of choice,
- The Rotaflow Console including the RotaflowDrive and the Rotaflow Emergency Drive,
Heart-Lung Machine HL 40
The advanced perfusion features of the HL 40 support appropriate treatment. A familiar, perfusionist-developed interface minimizes the learning curve to reduce use errors. The HL 40 is not yet commercially available. Contact your Getinge representative for more information.
HCU 40 Heater-Cooler Unit
Easy, rapid and precise temperature control are essential requirements for a hypo-/hyperthermia unit for use during extracorporeal circulation
Helps improve patient safety by providing clinicians with the information they need to make informed decisions. It assists the perfusionist by reducing the time spent on documentation and increases the time spent on patient care. Metavision Perfusion interfaces with heart-lung-machines from different vendors and retrieves data from other medical devices.
Quadrox-i Adult & Small Adult
A significant member of the family of oxygenators
Quadrox-i Neonatal & Pediatric
One of the world’s smallest oxygenator with an integrated arterial filter.
Rotaflow RF-32 Centrifugal Pump
One of the smallest centrifugal pumps available.
MECC-i for Cardiohelp System
Pioneering minimized perfusion.
Provides optimum conservation of patient blood and considerably minimize the need for homologous blood products.